Hosseinpour Fatemeh, Shomali Tahoora, Rafieian-Kopaei Mahmoud
.
J Complement Integr Med. 2017 Jun 1;14(4):/j/jcim.2017.14.issue-4/jcim-2017-0007/jcim-2017-0007.xml. doi: 10.1515/jcim-2017-0007.
Background Lipid profile disturbances are important risk factors for cardiovascular events in patients with diabetes mellitus and finding safe and multifaceted agents is persuaded in this regard. This study aimed to evaluate the effect of cornelian cherry dried powder (CCDP) on serum lipid profile as well as liver antioxidant capacity, HMG-CoA reductase level and activity, and LDL receptor level in streptozotocin-induced diabetic rats. Methods Forty-eight male adult Wistar rats were randomly allocated into eight equal groups and were treated for 4 weeks as follows: negative control (normal rats, basic diet); positive control (diabetic rats, basic diet), T1 to T4 groups: diabetic rats fed with basic diet containing 0.25, 0.5, 1 and 2 g/ 100 g BW CCDP, respectively; T5: diabetic rats fed with basic diet plus 10 mg/kg lovastatin in drinking water and T6: normal rats fed with basic diet containing 1 g/ 100 g BW CCDP. Results Administration of CCDP had no significant effect on serum glucose levels in diabetic rats however decreased total cholesterol, low-density lipoprotein cholesterol (LDL-C) and increased high-density lipoprotein cholesterol (HDL-C) levels and liver antioxidant capacity as compared to positive control rats (p<0.05). Although HMG-CoA reductase level showed a significant decrease only in T3 group, its activity was reduced in all diabetic CCDP and lovastatin-treated groups as compared to positive control. LDL receptor level remained statistically the same among positive control and CCDP-treated groups. Conclusions In conclusion, the present study confirms hypocholesterolemic effect of CCDP in diabetic rats and demonstrated that this effect was at least partly due to inhibition of liver HMG-CoA reductase activity.
脂质谱紊乱是糖尿病患者心血管事件的重要危险因素,因此寻找安全且具有多方面作用的药物很有必要。本研究旨在评估山茱萸干粉末(CCDP)对链脲佐菌素诱导的糖尿病大鼠血清脂质谱、肝脏抗氧化能力、HMG-CoA还原酶水平及活性和低密度脂蛋白受体水平的影响。方法:48只成年雄性Wistar大鼠随机分为8组,每组6只,进行如下4周治疗:阴性对照组(正常大鼠,基础饮食);阳性对照组(糖尿病大鼠,基础饮食),T1至T4组:分别给予含0.25、0.5、1和2 g/100 g体重CCDP的基础饮食的糖尿病大鼠;T5组:给予基础饮食加饮水中含10 mg/kg洛伐他汀的糖尿病大鼠;T6组:给予含1 g/100 g体重CCDP基础饮食的正常大鼠。结果:给予CCDP对糖尿病大鼠的血清葡萄糖水平无显著影响,但与阳性对照组相比,可降低总胆固醇、低密度脂蛋白胆固醇(LDL-C)水平,升高高密度脂蛋白胆固醇(HDL-C)水平及肝脏抗氧化能力(p<0.05)。虽然HMG-CoA还原酶水平仅在T3组显著降低,但其活性在所有糖尿病CCDP和洛伐他汀治疗组中均低于阳性对照组。阳性对照组和CCDP治疗组之间的LDL受体水平在统计学上无差异。结论:总之,本研究证实了CCDP对糖尿病大鼠具有降胆固醇作用,并表明这种作用至少部分归因于对肝脏HMG-CoA还原酶活性的抑制。